Tacrolimus (VIVUS)

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameTacrolimus (VIVUS)
Drug Alias NameSPI-026VI-0106
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionBone morphogenetic protein receptor type-2 modulatorsCalcineurin inhibitorsCytokines inhibitors +[4] 
TargetsBone morphogenetic protein receptor type-2CytokinesCalcineurin
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSelten PharmaStanford University
China Registration ClassN/A

Develop Information

Active CompaniesVivus Inc
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG